Overcoming challenges in treating autoimmuntity: development of tolerogenic immune-modifying nanoparticles

RM Pearson, JR Podojil, LD Shea, NJC King… - … , Biology and Medicine, 2019 - Elsevier
Autoimmune diseases, such as celiac disease, multiple sclerosis, and type 1 diabetes, are
leading causes of morbidity and mortality in the United States. In these disease states …

Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles

RM Pearson, JR Podojil, LD Shea… - Nanomedicine …, 2019 - pubmed.ncbi.nlm.nih.gov
Autoimmune diseases, such as celiac disease, multiple sclerosis, and type 1 diabetes, are
leading causes of morbidity and mortality in the United States. In these disease states …

Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles

RM Pearson, JR Podojil, LD Shea… - Nanomedicine …, 2019 - scholars.northwestern.edu
Autoimmune diseases, such as celiac disease, multiple sclerosis, and type 1 diabetes, are
leading causes of morbidity and mortality in the United States. In these disease states …

[HTML][HTML] Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles

RM Pearson, JR Podojil, LD Shea… - … biology, and medicine, 2019 - ncbi.nlm.nih.gov
Autoimmune diseases, such as celiac disease, multiple sclerosis, and type 1 diabetes, are
leading causes of morbidity and mortality in the United States. In these disease states …

Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles.

RM Pearson, JR Podojil, LD Shea… - Nanomedicine …, 2018 - europepmc.org
Autoimmune diseases, such as celiac disease, multiple sclerosis, and type 1 diabetes, are
leading causes of morbidity and mortality in the United States. In these disease states …